Home
IP public policy

Work Area: IP public policy

IPBC Global 2022 approaches sell-out territory

The world’s pre-eminent event focusing on IP value creation takes place in Chicago from 12 to 14 June with over 500 senior delegates set to attend

Moderna says US government on the hook to pay any royalties due to mRNA patent owners

The company claims any infringing uses of its vaccine are insulated from liability under compulsory licensing law

Qualcomm chief IP counsel: US IP system in decent shape but some current proposals could be “detrimental”

Bob Giles, top IP lawyer for the San Diego chip innovator, also says standards-setting process works well, downplaying concerns that it is being gamed

Latest content

Consequences in US anti-suit injunction bill not as strong as courts’ own remedies

The Senate's "Defending American Courts Act" aimed at curbing use of Chinese anti-suit injunctions in FRAND cases may not have much effect on litigants’ incentives

16 March 2022

Breakthrough in TRIPS covid waiver negotiations – here’s what you need to know

There are reports of a compromise deal agreeed by the US, EU, India and South Africa, but no official confirmation

16 March 2022

Vaccine hub leader welcomes new Moderna patent pledge, but calls for collaboration

Petro Terblanche speaks to IAM about the mRNA innovator’s expanded IP commitment

14 March 2022

Judge Kathleen O’Malley reveals inner thoughts on 101, PTAB reforms, patent injunctions and more

“I believe that there's a lot wrong with our IP system” Judge O’Malley tells IAM in an exclusive interview as she steps down from the US Court of Appeals for the Federal Circuit after 12 years to re-enter private practice and contribute to policy discussions

11 March 2022

Oppo suit in Guangzhou sets up next chance for global FRAND ruling in China

Chinese smartphone vendor selects Guangzhou IP Court for rate-setting case to counter InterDigital’s SEP claims around the world

09 March 2022

Russia's sanctions response takes aim at foreign IP owners

Proposal from top economic ministry is just one of several commercial risk-management issues to arise from Russian invasion of Ukraine

08 March 2022

UK patent attorneys may not get rights of audience at the UPC after all

New uncertainties over who may advocate before the new European court have arisen

04 March 2022

The EU WTO patent attack on China explored from every angle

Europe has anti-suit injunctions involving SEPs firmly in its sights, but there are multiple, highly complex issues at play and context is all important. Adam Houldsworth, Jacob Schindler, Joff Wild and Bing Zhao report

02 March 2022

Upcoming SEP fights will colour views of China’s judicial fairness

Aggregate stats have long shown that foreign IP owners fare well in China, but recent research published by IAM suggests SEP holders have justified concerns

26 February 2022

How manufacturing patents are shaping US biologics strategies

Study reveals the significance of manufacturing IP rights in BPCIA litigation

25 February 2022

Get unlimited access to all IAM content